Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 1992;19:333-338

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Johnson, R. A.
Right arrow Articles by Freeman, R. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Johnson, R. A.
Right arrow Articles by Freeman, R. H.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*(L)-ARGININE
*NITRIC OXIDE
*SODIUM

Hypertension, Vol 19, 333-338, Copyright © 1992 by American Heart Association


ARTICLES

Pressure natriuresis in rats during blockade of the L-arginine/nitric oxide pathway

RA Johnson and RH Freeman
Department of Physiology, University of Missouri, School of Medicine, Columbia 65212.

The natriuretic response was studied in anesthetized rats during the intravenous infusion of L-arginine analogues to inhibit the production of endothelium-derived nitric oxide. In an initial experimental series, rats were administered saline vehicle or vehicle containing 300 mumol/kg body wt N omega-monomethyl-L-arginine, N omega-nitro-L- arginine methyl ester, N omega-monomethyl-D-arginine, or L-arginine. Infusion of the competitive inhibitors N omega-monomethyl-L-arginine and N omega-nitro-L-arginine methyl ester significantly increased mean arterial pressure to 155 +/- 3 and 145 +/- 5 mm Hg, respectively, compared with a mean arterial pressure of 118 +/- 3 mm Hg determined in the vehicle control group. Sodium excretion averaged 3.27 +/- 1.08 and 2.52 +/- 0.78 mu eq/min in the N omega-monomethyl-L-arginine- and N omega-nitro-L-arginine methyl ester-treated rats, respectively, and each was significantly higher than the basal sodium excretion of 0.20 +/- 0.05 mu eq/min in the vehicle-treated control animals. Plasma renin activity was significantly lower in the N omega-monomethyl-L-arginine- and N omega-nitro-L-arginine methyl ester-treated groups than in the vehicle-treated group. Neither L-arginine nor N omega-monomethyl-D- arginine administration significantly altered any of the measured variables compared with vehicle alone. In a second experimental series, an adjustable snare was placed around the suprarenal aorta for the purpose of controlling renal perfusion pressure independently of increases in the systemic mean arterial pressure initiated by infusion of N omega-nitro-L-arginine methyl ester (75 mumol/kg i.v.).(ABSTRACT TRUNCATED AT 250 WORDS)


This article has been cited by other articles:


Home page
Am. J. Physiol. Renal Physiol.Home page
G. O. Ogungbade, L. A. Akinsanmi, H. Jiang, and A. O. Oyekan
Role of epoxyeicosatrienoic acids in renal functional response to inhibition of NO production in the rat
Am J Physiol Renal Physiol, November 1, 2003; 285(5): F955 - F964.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
H. C Hercule, M.-H. Wang, and A. O Oyekan
Contribution of cytochrome P450 4A isoforms to renal functional response to inhibition of nitric oxide production in the rat
J. Physiol., September 15, 2003; 551(3): 971 - 979.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
M. Obst, V. Gross, J. Janke, M. Wellner, W. Schneider, and F. C. Luft
Pressure Natriuresis in AT2 Receptor-Deficient Mice with L-NAME Hypertension
J. Am. Soc. Nephrol., February 1, 2003; 14(2): 303 - 310.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
A. Sener and F. G. Smith
Glomerular and tubular responses to NG-nitro-L-arginine methyl ester are age dependent in conscious lambs
Am J Physiol Regulatory Integrative Comp Physiol, May 1, 2002; 282(5): R1512 - R1520.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
A. Cases, J. Haas, J. C. Burnett, and J. C. Romero
Hemodynamic and renal effects of acute and progressive nitric oxide synthesis inhibition in anesthetized dogs
Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2001; 280(1): R143 - R148.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
A. Kurtz and C. Wagner
Role of nitric oxide in the control of renin secretion
Am J Physiol Renal Physiol, December 1, 1998; 275(6): F849 - F862.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
S. Y. Chin, C.-T. Wang, D. S. A. Majid, and L. G. Navar
Renoprotective effects of nitric oxide in angiotensin II-induced hypertension in the rat
Am J Physiol Renal Physiol, May 1, 1998; 274(5): F876 - F882.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
J. D. Krier and J. C. Romero
Systemic inhibition of nitric oxide and prostaglandins in volume-induced natriuresis and hypertension
Am J Physiol Regulatory Integrative Comp Physiol, January 1, 1998; 274(1): R175 - R180.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
P. R. Knoblich, R. H. Freeman, and D. Villarreal
Pressure-Dependent Renin Release During Chronic Blockade of Nitric Oxide Synthase
Hypertension, November 1, 1996; 28(5): 738 - 742.
[Abstract] [Full Text]


Home page
HypertensionHome page
S. S. Yamada, A. L. Sassaki, C. K. Fujihara, D. M. Avancini Costa Malheiros, G. De Nucci, and R. Zatz
Effect of Salt Intake and Inhibitor Dose on Arterial Hypertension and Renal Injury Induced by Chronic Nitric Oxide Blockade
Hypertension, May 1, 1996; 27(5): 1165 - 1172.
[Abstract] [Full Text]